These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 10536355

  • 1. MOC-31 aids in the differentiation of metastatic adenocarcinoma from hepatocellular carcinoma.
    Niemann TH, Hughes JH, De Young BR.
    Cancer; 1999 Oct 25; 87(5):295-8. PubMed ID: 10536355
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.
    Lin F, Abdallah H, Meschter S.
    Diagn Cytopathol; 2004 Feb 25; 30(2):92-7. PubMed ID: 14755758
    [Abstract] [Full Text] [Related]

  • 3. Use of the monoclonal antibody MOC-31 as an immunomarker for detecting metastatic adenocarcinoma in effusion cytology.
    Kundu UR, Krishnamurthy S.
    Cancer Cytopathol; 2011 Aug 25; 119(4):272-8. PubMed ID: 21732548
    [Abstract] [Full Text] [Related]

  • 4. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD, Rege JD, Joshi AS, Vaiphei K, Amarapurkar DN.
    Indian J Pathol Microbiol; 2006 Jul 25; 49(3):341-4. PubMed ID: 17001880
    [Abstract] [Full Text] [Related]

  • 5. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver.
    Ahuja A, Gupta N, Kalra N, Srinivasan R, Chawla Y, Rajwanshi A.
    Cytopathology; 2008 Aug 25; 19(4):229-35. PubMed ID: 18070122
    [Abstract] [Full Text] [Related]

  • 6. Monoclonal antibody MOC-31 reactivity as a marker for adenocarcinoma in cytologic preparations.
    Hecht JL, Pinkus JL, Pinkus GS.
    Cancer; 2006 Feb 25; 108(1):56-9. PubMed ID: 16329115
    [Abstract] [Full Text] [Related]

  • 7. Hepatocellular carcinoma versus carcinoma metastatic to the liver. Value of stains for carcinoembryonic antigen and naphthylamidase in fine needle aspiration biopsy material.
    Wong MA, Yazdi HM.
    Acta Cytol; 1990 Feb 25; 34(2):192-6. PubMed ID: 2157322
    [Abstract] [Full Text] [Related]

  • 8. The clinical utility of the Das-1 monoclonal antibody in identifying adenocarcinoma of the colon metastatic to the liver in fine-needle aspiration tissue.
    Zimmerman RL, Das KM, Burke MA, Young NA, Solomides CC, Bibbo M.
    Cancer; 2002 Dec 25; 96(6):370-3. PubMed ID: 12478685
    [Abstract] [Full Text] [Related]

  • 9. Recent immunohistochemical markers in the differential diagnosis of primary and metastatic carcinomas of the liver.
    Gokden M, Shinde A.
    Diagn Cytopathol; 2005 Sep 25; 33(3):166-72. PubMed ID: 16078249
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology.
    Saad RS, Luckasevic TM, Noga CM, Johnson DR, Silverman JF, Liu YL.
    Diagn Cytopathol; 2004 Jan 25; 30(1):1-6. PubMed ID: 14696137
    [Abstract] [Full Text] [Related]

  • 11. MOC-31 aids in the differentiation between adenocarcinoma and reactive mesothelial cells.
    Morgan RL, De Young BR, McGaughy VR, Niemann TH.
    Cancer; 1999 Dec 25; 87(6):390-4. PubMed ID: 10603193
    [Abstract] [Full Text] [Related]

  • 12. Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel.
    Saleh HA, Aulicino M, Zaidi SY, Khan AZ, Masood S.
    Diagn Cytopathol; 2009 Mar 25; 37(3):184-90. PubMed ID: 19170172
    [Abstract] [Full Text] [Related]

  • 13. HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates.
    Wang L, Vuolo M, Suhrland MJ, Schlesinger K.
    Acta Cytol; 2006 Mar 25; 50(3):257-62. PubMed ID: 16780018
    [Abstract] [Full Text] [Related]

  • 14. Polyclonal carcinoembryonic antigen staining in the cytologic differential diagnosis of primary and metastatic hepatic malignancies.
    Wolber RA, Greene CA, Dupuis BA.
    Acta Cytol; 1991 Mar 25; 35(2):215-20. PubMed ID: 1709323
    [Abstract] [Full Text] [Related]

  • 15. Hep par-1: a novel immunohistochemical marker for differentiating hepatocellular carcinoma from metastatic carcinoma.
    Hanif R, Mansoor S.
    J Coll Physicians Surg Pak; 2014 Mar 25; 24(3):186-9. PubMed ID: 24613115
    [Abstract] [Full Text] [Related]

  • 16. Comparison of thyroid transcription factor-1 and hepatocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adenocarcinoma, renal cell carcinoma, and adrenal cortical carcinoma.
    Wieczorek TJ, Pinkus JL, Glickman JN, Pinkus GS.
    Am J Clin Pathol; 2002 Dec 25; 118(6):911-21. PubMed ID: 12472285
    [Abstract] [Full Text] [Related]

  • 17. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.
    Johnston WW, Szpak CA, Thor A, Schlom J.
    Cancer Res; 1986 Dec 25; 46(12 Pt 1):6462-70. PubMed ID: 3022920
    [Abstract] [Full Text] [Related]

  • 18. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T, Herawi M, Epstein JI, Illei PB.
    Am J Surg Pathol; 2007 Sep 25; 31(9):1351-5. PubMed ID: 17721190
    [Abstract] [Full Text] [Related]

  • 19. Some cytologic features of hepatocellular carcinoma as seen in fine needle aspirates.
    Greene CA, Suen KC.
    Acta Cytol; 1984 Sep 25; 28(6):713-8. PubMed ID: 6095567
    [Abstract] [Full Text] [Related]

  • 20. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
    Shiran MS, Isa MR, Sherina MS, Rampal L, Hairuszah I, Sabariah AR.
    Malays J Pathol; 2006 Dec 25; 28(2):87-92. PubMed ID: 18376797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.